In conclusion, we identify that a host factor LCN2 associated with neutrophils through comprehensive analysis of public database and data from clinical influenza patient samples could be used as potential biomarkers of predicting severity of patients with IAV and SARS-CoV-2 infection and provide a new direction for targeted treatment of host factor in respiratory virus infection. Here, LCN2 is linked to influenza.